Keyphrases
Surgical Resection
100%
Stereotactic Body Radiation Therapy
100%
Stage I Lung Cancer
100%
Clinical Stage IA
50%
Radiation Therapy
30%
Non-small Cell Lung Cancer (NSCLC)
30%
Disease-specific Survival
30%
Local Tumor Control
30%
Overall Survival
20%
Local Recurrence
20%
Comorbidity Scores
20%
Surgical Patients
20%
Propensity Analysis
20%
Lung
10%
Treatment Options
10%
Hazard Ratio
10%
Forced Expiratory Volume in 1 Second (FEV1)
10%
Comorbidity
10%
Positron Emission Tomography
10%
Computed Tomography
10%
5-year Survival
10%
Disease-free Survival
10%
Clinical High Risk
10%
Scoring System
10%
Short-term Outcomes
10%
Surgery Patients
10%
Survival Disparities
10%
Surgical Treatment
10%
Stage IB
10%
Recurrent Disease
10%
Pulmonary Function
10%
3-year Survival
10%
Local Treatment
10%
Final Pathology
10%
Matched Comparison
10%
Propensity Score Analysis
10%
Early-stage Lung Cancer
10%
Confounding Effect
10%
Localized Disease
10%
Therapy Groups
10%
Comorbidity Index
10%
Carbon Dioxide
10%
Local Tumor Recurrence
10%
High-risk Surgical Patients
10%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Stereotactic Body Radiation Therapy
100%
Surgery
100%
Clinical Stage
60%
Comorbidity
40%
Diseases
40%
Neoplasm
30%
Disease Specific Survival
30%
Overall Survival
20%
Recurrent Disease
20%
Radiation Therapy
20%
Positron Emission Tomography-Computed Tomography
10%
Forced Expiratory Volume
10%
Lung Cancer
10%
Hazard Ratio
10%
Scoring System
10%
Tumor Recurrence
10%
Disease Free Survival
10%
Surgical Risk
10%
Local Therapy
10%
Lung Function
10%
Propensity Score Matching
10%
Carbon Monoxide
10%
Treatment of Non-Small Cell Lung Cancer
10%
Lung
10%